Literature DB >> 2396807

Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings.

M Arriaga1, H Curtin, H Takahashi, B E Hirsch, D B Kamerer.   

Abstract

An accepted staging system for squamous cell carcinoma of the external auditory meatus is currently lacking and would permit accurate comparison of treatment strategies and results for patients with this unusual neoplasm. In order to develop such a staging system we reviewed the prognostic variables and the accuracy of radiographic diagnosis in 39 patients undergoing temporal bone resection for squamous carcinoma of the external auditory meatus. Predictors of poor survival were extensive tumor involvement, facial nerve paralysis, middle ear involvement, and cervical or periparotid lymphadenopathy. In a comparison of 12 specific anatomic sites, computed tomography was found to be an accurate indicator of histopathologically proven tumor invasion. On the basis of this clinical radiographic-histopathologic analysis, we propose a TNM staging system for external auditory meatus carcinoma utilizing preoperative computed tomography and physical examination. This system fulfills the requirements of the American Joint Committee on Cancer that a staging system should provide a sound basis for therapeutic planning for cancer patients by describing the survival and resultant treatment of different patient groups in comparable form.

Entities:  

Mesh:

Year:  1990        PMID: 2396807     DOI: 10.1177/000348949009900909

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  45 in total

1.  Predictors of survival and recurrence after temporal bone resection for cancer.

Authors:  Luc G T Morris; Saral Mehra; Jatin P Shah; Mark H Bilsky; Samuel H Selesnick; Dennis H Kraus
Journal:  Head Neck       Date:  2011-09-23       Impact factor: 3.147

2.  A case of Basal cell carcinoma of external auditory canal.

Authors:  Beom-Jun Lee; Seong-Cheon Bae; Jae-Hong Lee; Kyoung-Ho Park
Journal:  Korean J Audiol       Date:  2012-09-20

3.  [Bilateral auditory canal squamous cell carcinoma].

Authors:  S Shagdarsuren; M Schwaab; M Kissler; J Lautermann; H Sudhoff
Journal:  HNO       Date:  2006-01       Impact factor: 1.284

4.  Long-Term Outcomes of Patients with Squamous Cell Carcinoma of the Temporal Bone after Concomitant Chemoradiotherapy.

Authors:  Kiyoto Shiga; Katsunori Katagiri; Daisuke Saitoh; Takenori Ogawa; Kenjiro Higashi; Hisanori Ariga
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-14

5.  Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato; Yuko Nakayama; Tetsuo Nonaka; Nobutaka Mizoguchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-31       Impact factor: 2.503

6.  Update on Surgical Outcomes of Lateral Temporal Bone Resection for Ear and Temporal Bone Malignancies.

Authors:  Sumi Sinha; Matthew M Dedmon; Matthew R Naunheim; Jennifer C Fuller; Stacey T Gray; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-10

7.  Management of lateral skull base tumours.

Authors:  Prathamesh S Pai; Aliasgar Moiyadi; Deepa Nair
Journal:  Indian J Surg Oncol       Date:  2010-11-21

8.  Lateral temporal bone resection for malignancy of external auditory meatus: our approach.

Authors:  M D Venkatesh; Ajith Nilakantan; Dilip Raghavan; Rakesh Datta; Gunjan Dwivedi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-10-22

9.  Bilateral squamous cell carcinoma of the temporal bones.

Authors:  Athanasios G Bibas; Michael J Gleeson
Journal:  Skull Base       Date:  2006-11

10.  Intraoperative radiation therapy as adjuvant treatment in locally advanced stage tumours involving the middle ear: a hypothesis-generating retrospective study.

Authors:  G Cristalli; G Mercante; L Marucci; A Soriani; S Telera; G Spriano
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.